Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergyMargarete Focke‐Tejkl(Medical University of Vienna), Rudolf Valenta(Medical University of Vienna)Journal of Allergy and Clinical ImmunologyNovember 16, 201410.1016/j.jaci.2014.09.012Cited by 140SaveCiteExport RISWatch citationsRelated PapersImmunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection|EBioMedicine|2016|56VVX001 Induces preS-Specific Antibodies Reacting to Common HBV Genotypes in Hepatitis B Virus (HBV) Carrier Mice|Vaccines|2025|0